It was 2007 when an article in the U.K. had taken Daval International Ltd. to task for not doing clinical trials on their drug, Aimspro. The article had brought up how, in seven years, only two very small trials had been done and of them, “one was inconclusive and the other was stopped early.”
Aimspro is only available in Britain under their “compassionate-use” regulations and that means, like CCSVI, patients have to use their own money to receive treatment. No health insurance companies (or state funded health regulators) will touch a non-FDA or non-MHRA approved therapy............. Read More - http://www.ms-uk.org/index.cfm/aimspro
The controversy behind goat’s blood for MS therapy
The controversy behind goat’s blood for MS therapy
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2202 Views
-
Last post by frodo
-
- 0 Replies
- 1851 Views
-
Last post by Petr75
-
- 0 Replies
- 1232 Views
-
Last post by NHE
-
- 2 Replies
- 1885 Views
-
Last post by frodo
-
- 0 Replies
- 10915 Views
-
Last post by NHE
-
- 0 Replies
- 2688 Views
-
Last post by NHE
-
- 0 Replies
- 2532 Views
-
Last post by frodo
-
- 1 Replies
- 1889 Views
-
Last post by frodo
-
- 0 Replies
- 1363 Views
-
Last post by frodo